Raymond James & Associates’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$111M Buy
1,327,349
+175,294
+15% +$14.7M 0.07% 246
2024
Q2
$88.7M Sell
1,152,055
-12,648
-1% -$974K 0.06% 281
2024
Q1
$79.8M Sell
1,164,703
-16,871
-1% -$1.16M 0.05% 302
2023
Q4
$68.3M Buy
1,181,574
+44,000
+4% +$2.54M 0.05% 311
2023
Q3
$60.1M Sell
1,137,574
-27,389
-2% -$1.45M 0.05% 310
2023
Q2
$63M Sell
1,164,963
-150,578
-11% -$8.14M 0.05% 308
2023
Q1
$65.8M Sell
1,315,541
-37,792
-3% -$1.89M 0.06% 292
2022
Q4
$62.6M Buy
1,353,333
+117,602
+10% +$5.44M 0.06% 293
2022
Q3
$47.9M Sell
1,235,731
-575,643
-32% -$22.3M 0.05% 328
2022
Q2
$67.5M Sell
1,811,374
-59,914
-3% -$2.23M 0.07% 260
2022
Q1
$82.9M Sell
1,871,288
-310,350
-14% -$13.7M 0.07% 241
2021
Q4
$92.7M Sell
2,181,638
-224,583
-9% -$9.54M 0.07% 230
2021
Q3
$104M Buy
2,406,221
+61,808
+3% +$2.68M 0.09% 197
2021
Q2
$100M Buy
2,344,413
+334,503
+17% +$14.3M 0.09% 195
2021
Q1
$77.7M Buy
2,009,910
+423,096
+27% +$16.4M 0.08% 221
2020
Q4
$57M Buy
1,586,814
+352,727
+29% +$12.7M 0.06% 258
2020
Q3
$47.2M Buy
1,234,087
+85,025
+7% +$3.25M 0.06% 272
2020
Q2
$40.3M Buy
1,149,062
+90,842
+9% +$3.19M 0.05% 290
2020
Q1
$34.5M Buy
1,058,220
+89,354
+9% +$2.92M 0.05% 286
2019
Q4
$43.8M Buy
968,866
+129,201
+15% +$5.84M 0.06% 302
2019
Q3
$34.2M Buy
839,665
+103,915
+14% +$4.23M 0.05% 356
2019
Q2
$31.6M Buy
735,750
+40,874
+6% +$1.76M 0.05% 385
2019
Q1
$26.7M Buy
694,876
+75,571
+12% +$2.9M 0.04% 423
2018
Q4
$21.9M Buy
619,305
+102,169
+20% +$3.61M 0.04% 440
2018
Q3
$19.9M Buy
517,136
+43,734
+9% +$1.68M 0.03% 532
2018
Q2
$15.5M Sell
473,402
-17,802
-4% -$582K 0.03% 618
2018
Q1
$13.4M Sell
491,204
-129,791
-21% -$3.55M 0.02% 633
2017
Q4
$15.4M Sell
620,995
-23,353
-4% -$579K 0.03% 570
2017
Q3
$18.8M Buy
644,348
+29,440
+5% +$859K 0.04% 480
2017
Q2
$17M Buy
614,908
+38,211
+7% +$1.06M 0.04% 488
2017
Q1
$14.3M Sell
576,697
-86,846
-13% -$2.16M 0.03% 521
2016
Q4
$14.4M Buy
663,543
+26,631
+4% +$576K 0.04% 487
2016
Q3
$15.2M Buy
636,912
+16,560
+3% +$394K 0.04% 447
2016
Q2
$14.5M Buy
620,352
+143,017
+30% +$3.34M 0.05% 412
2016
Q1
$8.98M Sell
477,335
-3,314
-0.7% -$62.3K 0.03% 563
2015
Q4
$8.86M Buy
480,649
+168,348
+54% +$3.1M 0.03% 559
2015
Q3
$5.13M Buy
312,301
+67,581
+28% +$1.11M 0.02% 742
2015
Q2
$4.33M Buy
244,720
+24,599
+11% +$435K 0.02% 882
2015
Q1
$3.91M Buy
220,121
+47,204
+27% +$838K 0.02% 870
2014
Q4
$2.29M Buy
172,917
+18,359
+12% +$243K 0.01% 1081
2014
Q3
$1.83M Sell
154,558
-26,486
-15% -$313K 0.01% 1147
2014
Q2
$2.31M Buy
181,044
+17,742
+11% +$227K 0.01% 1019
2014
Q1
$2.21M Buy
163,302
+17,475
+12% +$236K 0.02% 974
2013
Q4
$1.75M Buy
145,827
+117,982
+424% +$1.42M 0.01% 1034
2013
Q3
$327K Sell
27,845
-11,370
-29% -$134K ﹤0.01% 1750
2013
Q2
$364K Buy
+39,215
New +$364K ﹤0.01% 1641